Patient Guide: Long-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Age) With Migraine

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 86 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05707949
Status: ENROLLING_BY_INVITATION
Condition: Migraine Prophylaxis
Phase: PHASE3

Where You Can Participate

This study is available at 86 locations across the country.

Top locations include:
  • • Huntsville, Alabama
  • • Little Rock, Arkansas
  • • Anaheim, California
  • • And 83 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Long-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Age) With Migraine - Join Clinical Trial NCTNCT05707949

How to Join This Clinical Trial - NCTNCT05707949

Learn how to participate in this PHASE3 trial studying an investigational therapy for Migraine Prophylaxis. Current status: ENROLLING_BY_INVITATION.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Migraine Prophylaxis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Migraine Prophylaxis
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ENROLLING_BY_INVITATION
Study Identifier
NCTNCT05707949 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 86 locations. Find a study site near you:

Clinical Research Site

Huntsville, Alabama 35805-4046 - United States

Status: Contact for availability

Clinical Research Site

Little Rock, Arkansas 72211 - United States

Status: Contact for availability

Clinical Research Site

Anaheim, California 92805 - United States

Status: Contact for availability

Clinical Research Site

Lafayette, California 94549-4579 - United States

Status: Contact for availability

Clinical Research Site

Long Beach, California 90807 - United States

Status: Contact for availability

Clinical Research Site

Oceanside, California 92056 - United States

Status: Contact for availability

Clinical Research Site

San Jose, California 95124-4108 - United States

Status: Contact for availability

Clinical Research Site

Ft. Collins, Colorado 80528 - United States

Status: Contact for availability

Clinical Research Site

Gulf Breeze, Florida 32561-4495 - United States

Status: Contact for availability

Clinical Research Site

Homestead, Florida 33030-4613 - United States

Status: Contact for availability

And 76 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Migraine Prophylaxis:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships